The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...
The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...
Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...
CNS stimulants are a type of medication that can help with low energy and concentration caused by sleep disruptions from sleep apnea. Methylxanthine bronchodilators are muscle relaxers that make ...
Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...
Childhood asthma leads to over 10 million missed school days annually in the U.S., making it a significant contributor to chronic illness-related school absenteeism. In the U.S., nearly 25 million ...